Summit Therapeutics and Akeso Report Ivonescimab Survival Benefit
Miami, Florida, USA, September 2, 2026 Summit Therapeutics Inc. has reported that its partner Akeso Inc. achieved a statistically...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Miami, Florida, USA, September 2, 2026 Summit Therapeutics Inc. has reported that its partner Akeso Inc. achieved a statistically...
Tempe, Arizona, USA, September 2, 2026 GT Medical Technologies has announced Renown Regional Medical Center as the latest institution...
North Chicago, Illinois, USA, September 2, 2026 Allergan Aesthetics, an AbbVie company, has unveiled its new “Layered Beauty: The...
